Education
About Us
Working with TipRanks
Follow Us
Oncology Pharma (ONPH)
OTHER OTC:ONPH
ONPH Stock Chart & Stats
$0.01
>-$0.01(-50.00%)
At close: 4:00 PM EST
$0.01
>-$0.01(-50.00%)
Day’s Range― - ―
52-Week Range$0.00 - $1.05
Previous CloseN/A
Volume1.38K
Average Volume (3M)N/A
Market Cap
$109.55K
Enterprise ValueN/A
Total Cash (Recent Filing)$398.00
Total Debt (Recent Filing)$777.62K
Price to Earnings (P/E)―
Beta-64.71
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding27,388,216
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)90.64
Price to Sales (P/S)0.00
P/FCF Ratio306.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ONPH FAQ
What was Oncology Pharma’s price range in the past 12 months?
Oncology Pharma lowest stock price was $0.00 and its highest was $1.05 in the past 12 months.
What is Oncology Pharma’s market cap?
Oncology Pharma’s market cap is $109.55K.
When is Oncology Pharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Oncology Pharma’s earnings last quarter?
Currently, no data Available
Is Oncology Pharma overvalued?
According to Wall Street analysts Oncology Pharma’s price is currently Overvalued.
Does Oncology Pharma pay dividends?
Oncology Pharma does not currently pay dividends.
What is Oncology Pharma’s EPS estimate?
Oncology Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oncology Pharma have?
Oncology Pharma has 27,388,216 shares outstanding.
What happened to Oncology Pharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Oncology Pharma?
Currently, no hedge funds are holding shares in ONPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Oncology Pharma
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.
AIM ImmunoTech
―
Biodexa Pharmaceuticals
―
Salarius Pharmaceuticals
―
Scinai Immunotherapeutics
―
Oragenics
―
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---